Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study

Introduction: Combination of trastuzumab (T) and lapatinib (L) has been showed to significantly improve the prognosis of HER2+ heavily pretreated metastatic breast cancer (MBC). Whether TL combined chemotherapy (TLC) can further improve the efficacy in HER2+ MBC remains to be further studied. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yi, Gong, Chengcheng, Lu, Qianyi, Zhou, Zhaochun, Luo, Ting, Li, Wei, Li, Gang, Ge, Rui, Xu, Fei, Wang, Biyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062863/
https://www.ncbi.nlm.nih.gov/pubmed/32195186
http://dx.doi.org/10.3389/fonc.2020.00271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062863/
https://www.ncbi.nlm.nih.gov/pubmed/32195186
http://dx.doi.org/10.3389/fonc.2020.00271

Ejemplares similares